PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
Introduction Streptococcus pneumoniae is a causative agent of pneumonia and acute otitis
media (AOM), as well as invasive diseases such as meningitis and bacteremia. PCV15 …
media (AOM), as well as invasive diseases such as meningitis and bacteremia. PCV15 …
[HTML][HTML] Safety and tolerability of V114 pneumococcal vaccine in infants: a phase 3 study
N Banniettis, M Horn, M Sadarangani, SM Patel… - …, 2023 - publications.aap.org
BACKGROUND AND OBJECTIVES Disease caused by Streptococcus pneumoniae is
associated with considerable morbidity and mortality in children. Pneumococcal conjugate …
associated with considerable morbidity and mortality in children. Pneumococcal conjugate …
[HTML][HTML] Safety and immunogenicity of V114 in preterm infants: a pooled analysis of four phase three studies
TJ Chapman, SM Patel, SA Flores, S Xu… - The Pediatric …, 2023 - journals.lww.com
Background: Risk of invasive pneumococcal disease is 3-fold higher in preterm versus full-
term infants. V114 is a 15-valent pneumococcal conjugate vaccine (PCV) containing the 13 …
term infants. V114 is a 15-valent pneumococcal conjugate vaccine (PCV) containing the 13 …
Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6–8 weeks old healthy Indian Infants …
RV Matur, S Thuluva, S Gunneri, V Yerroju… - Vaccine, 2024 - Elsevier
Background Introduction of pneumococcal conjugate vaccines (PCVs) reduced the number
of cases of pneumococcal disease (PD). However, there is an increase in clinical and …
of cases of pneumococcal disease (PD). However, there is an increase in clinical and …
[HTML][HTML] Analysis of Adverse Events Post-13-Valent Pneumococcal Vaccination among Children in Hangzhou, China
J Wang, J Du, Y Liu, X Che, Y Xu, J Han - Vaccines, 2024 - mdpi.com
With the widespread use of the 13-valent pneumonia vaccine (PCV13) in China, monitoring
adverse events following immunization (AEFIs) is critical. We conducted a descriptive …
adverse events following immunization (AEFIs) is critical. We conducted a descriptive …
[HTML][HTML] Il nuovo vaccino coniugato antipneumococcico 15-valente per la prevenzione delle infezioni da S. pneumoniae in età pediatrica: una valutazione di HTA
L'Health Technology Assessment (HTA) è riconosciuto come lo strumento principe per
bilanciare l'esigenza di raggiungere la più ampia accessibilità/copertura possibile al netto …
bilanciare l'esigenza di raggiungere la più ampia accessibilità/copertura possibile al netto …
Pneumokokkenimpfung im Säuglings-und im Kleinkindalter
S Vygen-Bonnet, J Schlaberg, K Kremer-Flach… - Monatsschrift …, 2024 - Springer
Streptococcus pneumoniae verursacht verschiedene Erkrankungen im Kindesalter. Invasive
Pneumokokkenerkrankungen („invasive pneumococcal disease “, IPD) sind selten. Sie …
Pneumokokkenerkrankungen („invasive pneumococcal disease “, IPD) sind selten. Sie …
[HTML][HTML] Pneumococcal disease
N Territory, S Australia, W Australia - immunisationhandbook.health.gov …
The optimal pneumococcal vaccination program for Australia is currently under review. At
present Prevenar 13 (13vPCV) and Pneumovax 23 (23vPPV) are the pneumococcal …
present Prevenar 13 (13vPCV) and Pneumovax 23 (23vPPV) are the pneumococcal …
[HTML][HTML] Ein 15-valenter Pneumokokken-Impfstoff
E Gysling - pharma-kritik, 2023 - infomed.ch
PCV15 enthält die Kapsel-Polysaccharid-Antigene von 15 Pneumokokken-Serotypen,
konjugiert mit einem Proteinträger (eine nicht-toxische Variante des Diphtherietoxins). Das …
konjugiert mit einem Proteinträger (eine nicht-toxische Variante des Diphtherietoxins). Das …
[HTML][HTML] Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual …
S Feng, J McLellan, N Pidduck, N Roberts… - …, 2023 - thelancet.com
Background Vaccination of infants with pneumococcal conjugate vaccines (PCV) is
recommended by the World Health Organization. Evidence is mixed regarding the …
recommended by the World Health Organization. Evidence is mixed regarding the …